Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Yoshiki Kojo"'
Autor:
Hiroki Suzuki, Hideyuki Sato, Yoshiki Kojo, Takahiro Mizumoto, Kayo Yuminoki, Naohumi Hashimoto, Yoshiki Seto, Satomi Onoue
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 11, Iss 1, Pp 50-51 (2016)
Externí odkaz:
https://doaj.org/article/cbc8c1693e2e46dabb54b4ac02e41a0e
Autor:
Ken-ei Sada, Yoshiki Kojo, Jolyon Fairburn-Beech, Keiko Sato, Shoko Akiyama, Melissa K Van Dyke, Isao Mukai
Publikováno v:
Modern rheumatology. 32(2)
Objectives To estimate eosinophilic granulomatosis with polyangiitis (EGPA) prevalence and disease burden in patients with newly diagnosed EGPA in Japan. Methods This retrospective descriptive cohort study (GSK ID: 209751, HO-18-19652) used administr
Autor:
Satomi Onoue, Kayo Yuminoki, Yoshiki Kojo, Hiroki Suzuki, Hideyuki Sato, Yoshiki Seto, Naofumi Hashimoto, Yuuki Kaneko, Kouki Kato
Publikováno v:
International Journal of Pharmaceutics. 545:19-26
The present study aimed to clarify the applicability of a self-micellizing solid dispersion of tranilast (SMSD/TL) to the treatment of inflammatory bowel diseases (IBD) using an experimental colitis model. SMSD/TL with several loading amounts ranging
Autor:
Ken-ei Sada, Yoshiki Kojo, Jolyon, Fairburn-Beech, Keiko Sato, Shoko Akiyama, Melissa K., Van Dyke, Isao Mukai
Publikováno v:
Modern Rheumatology; Mar2022, Vol. 32 Issue 2, p380-386, 7p
Autor:
Yoshiki Seto, Yoshiki Kojo, Hiroki Suzuki, Kanako Kobayashi, Saori Matsunaga, Satomi Onoue, Hideyuki Sato
Publikováno v:
Drug Metabolism and Pharmacokinetics. 32:273-276
The present study was aimed to avoid pharmacokinetic transitions of itraconazole (ITZ) evoked by high-fat meal intake by employing a self-micellizing solid dispersion (SMSD) approach. The dissolution behavior of SMSD/ITZ was assessed in simulated gas
Publikováno v:
European Journal of Pharmaceutical Sciences. 97:55-61
The present study was aimed to evaluate the applicability of a self-micellizing solid dispersion (SMSD) system of itraconazole (ITZ) with the use of Soluplus® to achieve improved dissolution and stable oral absorption of ITZ under hypochlorhydric co
Autor:
Ryota Tsukada, Kouki Kato, Yoshiki Kojo, Hiroki Suzuki, Yoshiki Seto, Satomi Onoue, Yuuki Kaneko, Hideyuki Sato
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 90
The present study aimed to verify the efficacy of tranilast (TL) for treating inflammatory bowel disease (IBD) with the use of an experimental colitis model. The experimental colitis model was prepared by intrarectal instillation of 2,4,6-trinitroben
Autor:
Hideyuki Sato, Satomi Onoue, Hiroki Suzuki, Yoshiki Kojo, Kayo Yuminoki, Shizuo Yamada, Saori Matsunaga, Takahiro Mizumoto, Naofumi Hashimoto
Publikováno v:
European Journal of Pharmaceutical Sciences. 62:16-22
The present study aimed to develop a self-micellizing solid dispersion (SMSD) of cyclosporine A (CsA) using an amphiphilic block copolymer, poly[MPC-co-BMA], to improve the biopharmaceutical properties of CsA. The cytotoxicity of poly[MPC-co-BMA] was
Autor:
Yohei Kawabata, Yoshiki Kojo, Satomi Onoue, Naofumi Hashimoto, Kayo Yuminoki, Yukinori Yamauchi, Shizuo Yamada, Hiroki Suzuki, Keitatsu Kou
Publikováno v:
International Journal of Pharmaceutics. 452:220-226
The present study aimed to develop novel solid dispersion (SD) of tranilast (TL) using amphiphilic block copolymer, poly[MPC-co-BMA] (pMB), to improve the dissolution and pharmacokinetic behavior of TL. pMB-based SD of TL (pMB-SD/TL) with drug loadin
Autor:
Shizuo Yamada, Yohei Kawabata, Kumiko Ogawa, Takahiro Mizumoto, Satomi Onoue, Yoshiki Kojo, Hideyuki Sato
Publikováno v:
International Journal of Pharmaceutics. 448:282-289
The main objective of this study was to improve the safety and oxidative stability of glycerol monooleate (GMO)-based dry-emulsion (DE) formulation containing cyclosporine A (CsA) for inhalation therapy. GMO or highly purified GMO (hpGMO) was used as